Search
Now showing items 1-10 of 88
-
Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial
Journal for Immunotherapy of Cancer, 2021, 9 (10), e002998Article dans une revue scientifiquefulltext -
Switch in use of midazolam for cancer patients during the COVID-19 pandemic.
Journal of Oncology Pharmacy Practice, 16-08-2020, 1078155220948929Article dans une revue scientifique -
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature.
Cancer Medicine, 21-03-2021Article dans une revue scientifiquefulltext -
What should we remember from 2020?
Bulletin du cancer, 01-2021, 108 (1), P. 55-66Article dans une revue scientifiquefulltext -
Major impact of covid-19 national containment on activities in the french northern comprehensive cancer center
Medical Oncology, Springer Link, 17-02-2021, 38, 28Article dans une revue scientifiquefulltext -
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
ESMO Open, 08-2021, 6 (4), 100209Article dans une revue scientifiquefulltext -
La phase socle en oncologie : retour d’expérience sur les trois premières années d’application de la réforme du troisième cycle
Bulletin du Cancer, 10-02-2022Article dans une revue scientifique -
Myositis ossificans circumscripta after surgery and radiotherapy and during sunitinib treatment: a case report.
Journal of Medical Case Reports, 08-12-2022, 16, 454Article dans une revue scientifiquefulltext -
Determinants of the access to remote specialised services provided by national sarcoma reference centres
BMC Cancer, 2021, 21, 631Article dans une revue scientifiquefulltext -
Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study
European Journal of Cancer, 06-2021, 150, p. 108-118Article dans une revue scientifiquefulltext